Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Proc Natl Acad Sci U S A ; 119(42): e2205460119, 2022 10 18.
Artículo en Inglés | MEDLINE | ID: mdl-36215473

RESUMEN

Relapsing fever due to Borrelia hermsii is characterized by recurrent bacteremia episodes. However, infection of B. hermsii, if not treated early, can spread to various organs including the central nervous system (CNS). CNS disease manifestations are commonly referred to as relapsing fever neuroborreliosis (RFNB). In the mouse model of B. hermsii infection, we have previously shown that the development of RFNB requires innate immune cells as well as T cells. Here, we found that prior to the onset of RFNB, an increase in the systemic proinflammatory cytokine response followed by sustained levels of IP-10 concurrent with the CNS disease phase. RNA sequencing analysis of the spinal cord tissue during the disease phase revealed an association of the interleukin (IL)-17 signaling pathway in RFNB. To test a possible role for IL-17 in RFNB, we compared B. hermsii infection in wild-type and IL-17A-/- mice. Although the onset of bacteremia and protective anti-B. hermsii antibody responses occurred similarly, the blood-brain barrier permeability, proinflammatory cytokine levels, immune cell infiltration in the spinal cord, and RFNB manifestations were significantly diminished in IL-17A-/- mice compared to wild-type mice. Treatment of B. hermsii-infected wild-type mice with anti-IL-17A antibody ameliorated the severity of spinal cord inflammation, microglial cell activation, and RFNB. These data suggest that the IL-17 signaling pathway plays a major role in the pathogenesis of RFNB, and IL-17A blockade may be a therapeutic modality for controlling neuroborreliosis.


Asunto(s)
Bacteriemia , Fiebre Recurrente , Animales , Quimiocina CXCL10 , Citocinas , Interleucina-17 , Interleucinas , Ratones , Fiebre Recurrente/genética
2.
Gastroenterology ; 160(5): 1647-1661, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33307034

RESUMEN

BACKGROUND & AIMS: Gastrointestinal (GI) manifestations have been increasingly reported in patients with coronavirus disease 2019 (COVID-19). However, the roles of the GI tract in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are not fully understood. We investigated how the GI tract is involved in SARS-CoV-2 infection to elucidate the pathogenesis of COVID-19. METHODS: Our previously established nonhuman primate (NHP) model of COVID-19 was modified in this study to test our hypothesis. Rhesus monkeys were infected with an intragastric or intranasal challenge with SARS-CoV-2. Clinical signs were recorded after infection. Viral genomic RNA was quantified by quantitative reverse transcription polymerase chain reaction. Host responses to SARS-CoV-2 infection were evaluated by examining inflammatory cytokines, macrophages, histopathology, and mucin barrier integrity. RESULTS: Intranasal inoculation with SARS-CoV-2 led to infections and pathologic changes not only in respiratory tissues but also in digestive tissues. Expectedly, intragastric inoculation with SARS-CoV-2 resulted in the productive infection of digestive tissues and inflammation in both the lung and digestive tissues. Inflammatory cytokines were induced by both types of inoculation with SARS-CoV-2, consistent with the increased expression of CD68. Immunohistochemistry and Alcian blue/periodic acid-Schiff staining showed decreased Ki67, increased cleaved caspase 3, and decreased numbers of mucin-containing goblet cells, suggesting that the inflammation induced by these 2 types of inoculation with SARS-CoV-2 impaired the GI barrier and caused severe infections. CONCLUSIONS: Both intranasal and intragastric inoculation with SARS-CoV-2 caused pneumonia and GI dysfunction in our rhesus monkey model. Inflammatory cytokines are possible connections for the pathogenesis of SARS-CoV-2 between the respiratory and digestive systems.


Asunto(s)
COVID-19/transmisión , Gastroenteritis/patología , Tracto Gastrointestinal/patología , Pulmón/patología , Animales , Bronquios/metabolismo , Bronquios/patología , COVID-19/inmunología , COVID-19/metabolismo , COVID-19/patología , Prueba de Ácido Nucleico para COVID-19 , Caspasa 3/metabolismo , Citocinas/inmunología , Modelos Animales de Enfermedad , Mucosa Gástrica , Gastroenteritis/metabolismo , Gastroenteritis/virología , Tracto Gastrointestinal/inmunología , Tracto Gastrointestinal/metabolismo , Células Caliciformes/patología , Intestino Delgado/metabolismo , Intestino Delgado/patología , Antígeno Ki-67/metabolismo , Pulmón/diagnóstico por imagen , Pulmón/inmunología , Pulmón/metabolismo , Macaca mulatta , Mucosa Nasal , ARN Viral/aislamiento & purificación , Distribución Aleatoria , Recto/metabolismo , Recto/patología , SARS-CoV-2 , Tráquea/metabolismo , Tráquea/patología
3.
Gut Microbes ; 16(1): 2334970, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38563680

RESUMEN

Gastrointestinal (GI) infection is evidenced with involvement in COVID-19 pathogenesis caused by SARS-CoV-2. However, the correlation between GI microbiota and the distinct pathogenicity of SARS-CoV-2 Proto and its emerging variants remains unclear. In this study, we aimed to determine if GI microbiota impacted COVID-19 pathogenesis and if the effect varied between SARS-CoV-2 Proto and its variants. We performed an integrative analysis of histopathology, microbiomics, and transcriptomics on the GI tract fragments from rhesus monkeys infected with SARS-CoV-2 proto or its variants. Based on the degree of pathological damage and microbiota profile in the GI tract, five of SARS-CoV-2 strains were classified into two distinct clusters, namely, the clusters of Alpha, Beta and Delta (ABD), and Proto and Omicron (PO). Notably, the abundance of potentially pathogenic microorganisms increased in ABD but not in the PO-infected rhesus monkeys. Specifically, the high abundance of UCG-002, UCG-005, and Treponema in ABD virus-infected animals positively correlated with interleukin, integrins, and antiviral genes. Overall, this study revealed that infection-induced alteration of GI microbiota and metabolites could increase the systemic burdens of inflammation or pathological injury in infected animals, especially in those infected with ABD viruses. Distinct GI microbiota and metabolite profiles may be responsible for the differential pathological phenotypes of PO and ABD virus-infected animals. These findings improve our understanding the roles of the GI microbiota in SARS-CoV-2 infection and provide important information for the precise prevention, control, and treatment of COVID-19.


Asunto(s)
COVID-19 , Microbioma Gastrointestinal , Animales , SARS-CoV-2 , Virulencia , Macaca mulatta
4.
Sci Rep ; 12(1): 9844, 2022 06 14.
Artículo en Inglés | MEDLINE | ID: mdl-35701460

RESUMEN

Chikungunya virus (CHIKV), a highly infectious and rapidly spread viral pathogen, is classified as a pathogenic agent at the biosafety level 3. Operation of live authentic CHIKV needs a specific laboratory with the P3 or above containment, which greatly confines the CHIKV-associated studies. To establish an evaluation system of CHIKV that can be utilized in a BSL2 laboratory, we constructed a pseudovirus (PsV) system of CHIKV containing double reporter genes (ZsGreen1 and luciferase). The fluorescent ZsGreen1 is a convenient and cheap reporter for monitoring the efficiency of transfection and titration of PsV. The enzyme luciferase is a sensitive reporter for the application of PsV to neutralization assay or drug screening. The CHIKV PsV produced in this study, with a titer of up to 3.16 × 106 TU/ml, was confirmed by Western blotting and transmission electronic microscopy (TEM). Finally, we developed a microneutralization assay with the CHIKV PsV produced in this study, which was successfully applied to evaluate neutralizing activities of convalescent sera from CHIKV-infected patients. In summary, we have established a convenient and sensitive double-reporter CHIKV pseudovirus system, which provides a safe and effective platform for screening anti-CHIKV drugs and evaluating vaccines against CHIKV.


Asunto(s)
Fiebre Chikungunya , Virus Chikungunya , Anticuerpos Neutralizantes , Anticuerpos Antivirales , Fiebre Chikungunya/diagnóstico , Virus Chikungunya/genética , Genes Reporteros , Humanos , Luciferasas/genética , Pruebas de Neutralización
5.
Signal Transduct Target Ther ; 6(1): 169, 2021 04 24.
Artículo en Inglés | MEDLINE | ID: mdl-33895780

RESUMEN

Neurological manifestations are frequently reported in the COVID-19 patients. Neuromechanism of SARS-CoV-2 remains to be elucidated. In this study, we explored the mechanisms of SARS-CoV-2 neurotropism via our established non-human primate model of COVID-19. In rhesus monkey, SARS-CoV-2 invades the CNS primarily via the olfactory bulb. Thereafter, viruses rapidly spread to functional areas of the central nervous system, such as hippocampus, thalamus, and medulla oblongata. The infection of SARS-CoV-2 induces the inflammation possibly by targeting neurons, microglia, and astrocytes in the CNS. Consistently, SARS-CoV-2 infects neuro-derived SK-N-SH, glial-derived U251, and brain microvascular endothelial cells in vitro. To our knowledge, this is the first experimental evidence of SARS-CoV-2 neuroinvasion in the NHP model, which provides important insights into the CNS-related pathogenesis of SARS-CoV-2.


Asunto(s)
Encefalopatías/metabolismo , Encéfalo/metabolismo , COVID-19/metabolismo , Bulbo Olfatorio/metabolismo , SARS-CoV-2/metabolismo , Animales , Astrocitos/metabolismo , Astrocitos/patología , Astrocitos/virología , Encéfalo/patología , Encéfalo/virología , Encefalopatías/patología , Encefalopatías/virología , COVID-19/patología , Modelos Animales de Enfermedad , Humanos , Macaca mulatta , Microglía/metabolismo , Microglía/patología , Microglía/virología , Neuronas/metabolismo , Neuronas/patología , Neuronas/virología , Bulbo Olfatorio/patología , Bulbo Olfatorio/virología
6.
Sci Rep ; 10(1): 16007, 2020 09 29.
Artículo en Inglés | MEDLINE | ID: mdl-32994418

RESUMEN

Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a pandemic event in the world, it has not only caused huge economic losses, but also a serious threat to global public health. Many scientific questions about SARS-CoV-2 and Coronavirus disease (COVID-19) were raised and urgently need to be answered, including the susceptibility of animals to SARS-CoV-2 infection. Here we tested whether tree shrew, an emerging experimental animal domesticated from wild animal, is susceptible to SARS-CoV-2 infection. No clinical signs were observed in SARS-CoV-2 inoculated tree shrews during this experiment except the increasing body temperature particularly in female animals. Low levels of virus shedding and replication in tissues occurred in all three age groups. Notably, young tree shrews (6 months to 12 months) showed virus shedding at the earlier stage of infection than adult (2 years to 4 years) and old (5 years to 7 years) animals that had longer duration of virus shedding comparatively. Histopathological examine revealed that pulmonary abnormalities were the main changes but mild although slight lesions were also observed in other tissues. In summary, tree shrew is less susceptible to SARS-CoV-2 infection compared with the reported animal models and may not be a suitable animal for COVID-19 related researches. However, tree shrew may be a potential intermediate host of SARS-CoV-2 as an asymptomatic carrier.


Asunto(s)
Infecciones por Coronavirus/veterinaria , Especificidad del Huésped/fisiología , Pandemias/veterinaria , Neumonía Viral/veterinaria , Tupaiidae/virología , Animales , Betacoronavirus , COVID-19 , Infecciones por Coronavirus/patología , Susceptibilidad a Enfermedades/veterinaria , Susceptibilidad a Enfermedades/virología , Femenino , Masculino , Neumonía Viral/patología , SARS-CoV-2 , Carga Viral , Esparcimiento de Virus/fisiología
7.
Signal Transduct Target Ther ; 5(1): 157, 2020 10 19.
Artículo en Inglés | MEDLINE | ID: mdl-32814760

RESUMEN

Identification of a suitable nonhuman primate (NHP) model of COVID-19 remains challenging. Here, we characterized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in three NHP species: Old World monkeys Macaca mulatta (M. mulatta) and Macaca fascicularis (M. fascicularis) and New World monkey Callithrix jacchus (C. jacchus). Infected M. mulatta and M. fascicularis showed abnormal chest radiographs, an increased body temperature and a decreased body weight. Viral genomes were detected in swab and blood samples from all animals. Viral load was detected in the pulmonary tissues of M. mulatta and M. fascicularis but not C. jacchus. Furthermore, among the three animal species, M. mulatta showed the strongest response to SARS-CoV-2, including increased inflammatory cytokine expression and pathological changes in the pulmonary tissues. Collectively, these data revealed the different susceptibilities of Old World and New World monkeys to SARS-CoV-2 and identified M. mulatta as the most suitable for modeling COVID-19.


Asunto(s)
Betacoronavirus/patogenicidad , Callithrix/virología , Infecciones por Coronavirus/epidemiología , Modelos Animales de Enfermedad , Macaca fascicularis/virología , Macaca mulatta/virología , Pandemias , Neumonía Viral/epidemiología , Animales , Anticuerpos Antivirales/biosíntesis , Betacoronavirus/inmunología , Temperatura Corporal , Peso Corporal , COVID-19 , Callithrix/inmunología , Infecciones por Coronavirus/diagnóstico por imagen , Infecciones por Coronavirus/inmunología , Infecciones por Coronavirus/patología , Citocinas/biosíntesis , Citocinas/clasificación , Citocinas/inmunología , Susceptibilidad a Enfermedades , Femenino , Humanos , Pulmón/diagnóstico por imagen , Pulmón/inmunología , Pulmón/patología , Pulmón/virología , Macaca fascicularis/inmunología , Macaca mulatta/inmunología , Masculino , Neumonía Viral/diagnóstico por imagen , Neumonía Viral/inmunología , Neumonía Viral/patología , SARS-CoV-2 , Especificidad de la Especie , Tomografía Computarizada por Rayos X , Carga Viral , Replicación Viral
8.
Zhongguo Zhen Jiu ; 31(9): 795-8, 2011 Sep.
Artículo en Zh | MEDLINE | ID: mdl-21972626

RESUMEN

OBJECTIVE: To verify the efficacy of electroacupuncture (EA) and acupoint injection on early postoperative intestinal obstruction and explore its mechanism. METHODS: One hundred and sixteen cases were divided randomly into two groups. In control group (56 cases), the conventional western medicine was applied, including gastrointestinal decompression, parenteral nutrition (PN), anti-inflammation and supporting therapy. In observation group (60 cases), on the basis of the treatment as control group, EA and acupoint injection with Neostigmine were supplemented. Zusanli (ST 36), Shangjuxu (ST 37)/Xiajuxu (ST 39) and Dachangshu (BL 25) were selected as main points. Before treatment and after 3 days treatment, the levels of plasma interleukint (IL-6), tumor necrosis factor-alpha (TNF-alpha) and motilin (MOT) were determined. RESULTS: In observation group, the mean recovery time of bowel sound and the mean frequency of passing gas were less than those in control group (both P < 0.01). After treatment, in either group, the levels of IL-6 and TNF-alpha were down-regulated as compared with those before treatment (all P < 0.01). After treatment, in observation group, IL-6 level was (15.2 +/- 4.1) pg/mL and TNF-alpha level was (18.3 +/- 6.5) pg/mL. They were (35.5 +/- 7.2) pg/mL and (52.7 +/- 12.3) pg/mL respectively in control group, indicating significant difference in statistics between two groups (both P < 0.01). In either group, MOT level increased after treatment as compared with that before treatment (both P < 0 01). After treatment, in observation group, the increase of MOT level was superior to that in control group [(190.7 +/- 48. 5 ) pg/mL vs (114.6 +/- 36.9) pg/mL, P < 0.01]. CONCLUSION: Electroacupuncture and acupoint injection are significantly effective in the treatment of early postoperative intestinal obstruction. This therapy may inhibit the release of inflammatory factors to reduce intestinal wall edema and it may promote MOT secretion to increase intestinal peristalsis. As a result, the recovery of gastrointestinal function is promoted.


Asunto(s)
Puntos de Acupuntura , Citocinas/sangre , Electroacupuntura , Inflamación/terapia , Obstrucción Intestinal/terapia , Motilina/sangre , Complicaciones Posoperatorias/terapia , Adulto , Anciano , Femenino , Humanos , Inyecciones , Masculino , Persona de Mediana Edad
9.
Zhongguo Zhen Jiu ; 30(1): 27-30, 2010 Jan.
Artículo en Zh | MEDLINE | ID: mdl-20353110

RESUMEN

OBJECTIVE: To search for a better therapy for early postoperative inflammatory small bowel obstruction (EPISBO). METHODS: Two hundred and forty cases were divided into four groups according to admitting order, 60 cases in each group. Routine treatments in western medicine were used in group A including gastrointestinal decompression, parenteral nutrition, anti-infection, supportive therapy and so on. Group B was treated with electroacupuncture in Zusanli (ST 36), Shangjuxu (ST 37) etc. in addition to those given in group A. Group C was treated with acupoint injection with Neostigmine in Dachangshu (BL 25), Zusanli (ST 36) etc. in addition to the treatment used in group A. Group D was treated with all of the treatments used in group A, B and C. RESULTS: The total effective rate was 93. 3% in group A, 96. 7% in group B, 100.0% in group C and group D. There was no significant difference among the four groups (P>0. 05). The average recovery time of bowel sound was (11. 512. 9) days in group A, (9. 3 +/- 2.5) days in group B, (5.6 +/- 3.5) days in group C and (2. 2 +/- 1.7) days in group D. The average anal exsufflation time was (12. 5 +/- 3. 1) days in group A, (10. 7 +/- 3.6) days in group B, (7. 2 +/- 3. 1) days in group C and (2. 5 +/- 1. 5) days in group D. Group D was superior to those of other three groups obviously, and there were significant differences between them (all P<0. 01). CONCLUSION: Electroacupuncture combined with acupoint injection has a satisfied therapeutic effect for treatment of EPISBO.


Asunto(s)
Puntos de Acupuntura , Electroacupuntura , Obstrucción Intestinal/inmunología , Neostigmina/administración & dosificación , Complicaciones Posoperatorias/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Terapia Combinada , Femenino , Humanos , Inyecciones , Obstrucción Intestinal/cirugía , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/inmunología , Complicaciones Posoperatorias/terapia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA